在使用左心室辅助装置的患者中严重肥胖
Cathlyn K Medina1, Stephanie G Barnes2, G Michael Felker3
1Duke University School of Medicine, Durham, North Carolina.
American heart journal
|June 12, 2024
概括
接受左心室辅助装置 (LVAD) 支持的严重肥胖患者年轻,不成比例的黑人,可能是女性. 解决肥胖问题对于改善心脏移植公平性和结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 健康 公平 卫生 公平
背景情况:
- 肥胖与晚期心力衰竭患者左心室辅助器件 (LVAD) 并发症的增加有关.
- 患有晚期心力衰竭的肥胖患者可能会面临心脏移植的障碍,并经历健康不平等.
- 需要LVAD支持的晚期心力衰竭患者中很大一部分患有严重肥胖 (BMI≥35 kg/m2).
研究的目的:
- 在一个活跃的LVAD队列中调查严重肥胖患者的特征.
- 了解肥胖对心脏移植资格和晚期心力衰竭的结果的影响.
主要方法:
- 在一个机构对一个活跃的LVAD患者队列的回顾性分析.
- 检查人口统计和临床数据,包括体重指数 (BMI).
主要成果:
- 近三分之一的LVAD队列呈现严重肥胖 (BMI≥35 kg/m2).
- 患有LVAD和严重肥胖症的患者明显年轻.
- 这个子组更有可能自我认同为黑人,并且在数量上更有可能是女性.
结论:
- 在需要LVAD支持的晚期心力衰竭患者中,严重肥胖很普遍.
- 体重管理对于解决心脏移植获取和结果的差异至关重要.
- 针对肥胖的干预措施可以在先进的心力衰竭护理中促进更大的健康公平.
相关概念视频
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Obesity
453
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
453
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570


